Epigenetic therapy for breast cancer

Area of Science:

• Oncology
• Epigenetics
• Cancer Biology

Background:

• Cancer progression is influenced by both genetic and epigenetic alterations.
• Genetic alterations are permanent, whereas epigenetic alterations are reversible.
• Reversibility makes epigenetic modifications a preferred target for therapeutic intervention.

Purpose of the Study:

• To highlight the therapeutic potential of targeting epigenetic modifications in cancer treatment.
• To emphasize the advantage of reversible epigenetic alterations over irreversible genetic changes in therapy.
• To discuss the role of DNA methyltransferases and histone deacetylases as key epigenetic targets.

Main Methods:

• Review of current research on epigenetic alterations in cancer.
• Analysis of epigenetic therapy targets, including DNA methyltransferases and histone deacetylases.
• Examination of approved epigenetic drugs and their efficacy.

Main Results:

• Epigenetic modifications offer a reversible approach to cancer treatment.
• DNA methylation inhibitors and histone deacetylation inhibitors are validated anti-cancer agents.
• Epigenetic targets demonstrate significant potential for sustained therapeutic benefits.

Conclusions:

• Epigenetic therapy presents a promising and potentially lasting strategy for cancer treatment.
• Targeting epigenetic mechanisms, particularly in breast cancer, holds significant therapeutic promise.
• The reversibility of epigenetic changes offers a distinct advantage over genetic alterations in cancer therapy.